These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8508366)

  • 1. Oligodendroglioma. The Princess Margaret Hospital experience (1958-1984).
    Nijjar TS; Simpson WJ; Gadalla T; McCartney M
    Cancer; 1993 Jun; 71(12):4002-6. PubMed ID: 8508366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of postoperative irradiation in the treatment of oligodendroglioma.
    Gannett DE; Wisbeck WM; Silbergeld DL; Berger MS
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):567-73. PubMed ID: 7928487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma.
    Yeh SA; Lee TC; Chen HJ; Lui CC; Sun LM; Wang CJ; Huang EY
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1405-9. PubMed ID: 12459363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients.
    Ozyigit G; Onal C; Gurkaynak M; Soylemezoglu F; Zorlu F
    J Neurooncol; 2005 Nov; 75(2):189-93. PubMed ID: 16132506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon.
    Sunyach MP; Pommier P; Martel Lafay I; Guyotat J; Ginestet G; Jouanneau E; Jouvet A; Sindou M; Bret P; Carrie C; Frappaz D
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):296-303. PubMed ID: 12694851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of anaplastic oligodendrogliomas and mixed gliomas.
    Kyritsis AP; Yung WK; Bruner J; Gleason MJ; Levin VA
    Neurosurgery; 1993 Mar; 32(3):365-70; discussion 371. PubMed ID: 8455760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of oligodendrogliomas with or without postoperative irradiation.
    Wallner KE; Gonzales M; Sheline GE
    J Neurosurg; 1988 May; 68(5):684-8. PubMed ID: 3357029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma.
    Lindegaard KF; Mørk SJ; Eide GE; Halvorsen TB; Hatlevoll R; Solgaard T; Dahl O; Ganz J
    J Neurosurg; 1987 Aug; 67(2):224-30. PubMed ID: 3598683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglioma: an analysis of prognostic factors and treatment results.
    Allam A; Radwi A; El Weshi A; Hassounah M
    Am J Clin Oncol; 2000 Apr; 23(2):170-5. PubMed ID: 10776979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendroglioma. An analysis of the value of radiation therapy.
    Bullard DE; Rawlings CE; Phillips B; Cox EB; Schold SC; Burger P; Halperin EC
    Cancer; 1987 Nov; 60(9):2179-88. PubMed ID: 3440228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases.
    Turgut M; Tahta K; Ozcan OE; Onol B
    Neurosurg Rev; 1998; 21(2-3):138-46. PubMed ID: 9795948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
    Soffietti R; Rudà R; Bradac GB; Schiffer D
    Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral oligodendroglioma: prognostic factors and life history.
    Celli P; Nofrone I; Palma L; Cantore G; Fortuna A
    Neurosurgery; 1994 Dec; 35(6):1018-34; discussion 1034-5. PubMed ID: 7885546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of oligodendrogliomas.
    Shimizu KT; Tran LM; Mark RJ; Selch MT
    Radiology; 1993 Feb; 186(2):569-72. PubMed ID: 8421767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed oligoastrocytomas: a survival and prognostic factor analysis.
    Shaw EG; Scheithauer BW; O'Fallon JR; Davis DH
    Neurosurgery; 1994 Apr; 34(4):577-82; discussion 582. PubMed ID: 8008153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendroglioma: the Rotterdam-Dijkzigt experience.
    Kros JM; Pieterman H; van Eden CG; Avezaat CJ
    Neurosurgery; 1994 Jun; 34(6):959-66; discussion 966. PubMed ID: 8084406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglioma: clinical profile and treatment results.
    Jacob R; Jyothirmayi R; Dalal Y; Nambiar U; Rajan B; Nair MK
    Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
    ; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperierre N; Mehta M; Curran W
    J Clin Oncol; 2006 Jun; 24(18):2707-14. PubMed ID: 16782910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendroglioma: does deferring treatment compromise outcome?
    Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
    Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of oligodendroglioma: an update.
    Paleologos NA; Cairncross JG
    Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.